Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
ADXBladder molecular urine testing to risk stratify and prioritise management of suspected and known bladder cancers during the COVID-19 pandemic
QMRO Home
School of Biological and Chemical Sciences
Cell and Molecular Biology
ADXBladder molecular urine testing to risk stratify and prioritise management of suspected and known bladder cancers during the COVID-19 pandemic
QMRO Home
School of Biological and Chemical Sciences
Cell and Molecular Biology
ADXBladder molecular urine testing to risk stratify and prioritise management of suspected and known bladder cancers during the COVID-19 pandemic
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
ADXBladder molecular urine testing to risk stratify and prioritise management of suspected and known bladder cancers during the COVID-19 pandemic
DOI
10.1177/20514158221086692
Journal
JOURNAL OF CLINICAL UROLOGY
ISSN
2051-4158
Metadata
Show full item record
Authors
Santiapillai, J; Foster, L; Allchorne, P; Green, JSA; Mohamud, H; Almushatat, A; Patki, P; Nawaz, H; Stevens, M; Rajan, P
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/79473
Collections
Cell and Molecular Biology
[194]